Your browser doesn't support javascript.
loading
Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
Rodríguez-García, Carlota; Blanco-Aparicio, Marina; Nieto-Fontarigo, Juan José; Blanco-Cid, Nagore; Gonzalez-Fernandez, Coral; Mosteiro-Añon, Mar; Calvo-Alvarez, Uxío; Perez-De-Llano, Luis; Corbacho-Abelaira, María Dolores; Lourido-Cebreiro, Tamara; Dominguez-Juncal, Luis Miguel; Crespo-Diz, Carlos; Dacal-Quintas, Raquel; Pallares-Sanmartin, Abel; Dacal-Rivas, David; Gonzalez-Barcala, Francisco Javier.
Afiliación
  • Rodríguez-García C; Department of Respiratory Medicine, University Hospital of Santiago de Compostela, Spain; Translational Research in Airway Diseases Group (TRIAD)-Health Research Institute of Santiago de Compostela (IDIS), Spain.
  • Blanco-Aparicio M; Department of Respiratory Medicine, University Hospital of A Coruña, Spain.
  • Nieto-Fontarigo JJ; Translational Research in Airway Diseases Group (TRIAD)-Health Research Institute of Santiago de Compostela (IDIS), Spain; Respiratory Immunopharmacology Group, Department of Experimental Medical Science, Lund University, Sweden. Electronic address: juanjose.nieto.fontarigo@gmail.com.
  • Blanco-Cid N; Department of Respiratory Medicine, University Hospital Lucus Augusti, Spain.
  • Gonzalez-Fernandez C; Department of Respiratory Medicine, University Hospital of Ourense, Spain.
  • Mosteiro-Añon M; Department of Respiratory Medicine, University Hospital Alvaro Cunqueiro, Spain.
  • Calvo-Alvarez U; Department of Respiratory Medicine, University Hospital of El Ferrol, Spain.
  • Perez-De-Llano L; Department of Respiratory Medicine, University Hospital Lucus Augusti, Spain.
  • Corbacho-Abelaira MD; Department of Respiratory Medicine, Ribera Hospital POVISA of Vigo, Spain.
  • Lourido-Cebreiro T; Department of Respiratory Medicine, University Hospital of Santiago de Compostela, Spain.
  • Dominguez-Juncal LM; Department of Respiratory Medicine, University Hospital of A Coruña, Spain.
  • Crespo-Diz C; Department of Hospital Pharmacy, University Hospital of Pontevedra, Spain; Health Research Institute of Galicia Sur, Spain.
  • Dacal-Quintas R; Department of Respiratory Medicine, University Hospital of Ourense, Spain.
  • Pallares-Sanmartin A; Department of Respiratory Medicine, University Hospital of Pontevedra, Spain.
  • Dacal-Rivas D; Department of Respiratory Medicine, University Hospital Lucus Augusti, Spain.
  • Gonzalez-Barcala FJ; Department of Respiratory Medicine, University Hospital of Santiago de Compostela, Spain; Translational Research in Airway Diseases Group (TRIAD)-Health Research Institute of Santiago de Compostela (IDIS), Spain; Department of Medicine, University of Santiago de Compostela, Spain; Spanish Biomedical
Respir Med ; 187: 106595, 2021 10.
Article en En | MEDLINE | ID: mdl-34492540
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Eosinofilia / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Med Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Eosinofilia / Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Med Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido